Acute myeloid leukaemia trials in France

In France 87 Also abroad 763

87 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy
Where
Angers, Annecy, Avignon, Bayonne, Besançon, Brest, Clermont-Ferrand, Colmar, Grenoble, Marseille, Metz, Montpellier, Mulhouse, Nantes, Nîmes, Orléans, Paris, Perpignan, Pessac, Poitiers, Reims, Rennes, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy
Age
60 years and over
People
1,000
Run by
French Innovative Leukemia Organisation
See details and how to joinNCT06891144
No phaseTaking people
Characterization of the Mechanisms of Resistance to Azacitidine
Where
Antibes, Nice
Age
18 years and over
People
250 worldwide
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT01210274
No phaseTaking people
Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)
Where
Caen
Age
60 years to 90 years
People
100
Run by
University Hospital, Caen
See details and how to joinNCT06045819
Phase 1/2Taking people
First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
Where
Marseille, Paris, Pierre-Bénite
Age
18 years and over
People
36
Run by
Advanced BioDesign
See details and how to joinNCT05601726
Phase 1/2Not yet taking people in France
An adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerability, and clinical activity in patients with relapsed/refractory acute myeloid leukaemia (RESOLVE AML 001)
Where
Besancon Cedex, Paris
Age
18 years and over
People
61 worldwide
Run by
CanCell Therapeutics
See details and how to join2023-506865-71-00
No phaseTaking people
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
Where
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, La Réunion, Lille, Limoges, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg, Toulouse, Tours
Age
Up to 25 years
People
500
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05772559
No phaseTaking people
The Patient Cohort of the National Center for Precision Medicine in Leukemia
Where
Bobigny, Paris
People
3,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05326919
Phase 1/2Taking people
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Where
Amiens, Bobigny, Caen, Créteil, Lyon, Marseille, Nice, Paris, Rouen, Tours, Versailles, Villejuif
Age
60 years and over
People
64
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05580861
No phaseTaking people
Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia
Where
Paris
Age
18 years to 100 years
People
120
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06225128
Phase 2Active, not recruiting
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Where
Amiens Cedex 1, Angers, Besancon Cedex, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, La Tronche, Lille Cedex, Limoges Cedex 1, Lyon, Marseille, Montpellier, Nantes Cedex 1, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, Saint-Denis, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy Cedex
Age
Up to 18 years
People
89 worldwide
Run by
Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00
No phaseNot yet taking people in France
Role of BMP Pathway in MDS Progression
Where
Lyon
Age
20 years and over
People
60
Run by
Hospices Civils de Lyon
See details and how to joinNCT06175923
No phaseNot yet taking people in France
Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry
Where
Amiens, Caen, Lille, Rouen
Age
18 years to 75 years
People
120
Run by
University Hospital, Caen
See details and how to joinNCT05161026